One hundred thirty-eight children 6-10 years of age with diagnosed HeFH or clinically important nonFH ( low-density lipoprotein cholesterol [ LDL-C ] 160 mg/dL [ 4.1 mmol/L ] ) were enrolled into a multicenter , 12-week , randomized , double-blind , placebo-controlled study .